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artery was noted in case of re-do procedures, though vessel wall
irregularities was noted in few cases.
Conclusion: Postprocedural patency in radial interventions
depends upon the nature and complexity of the coronary disease.
Females were more prone to develop puncture site complications.
Tobacco usage has the strongest association with the postproce-
dural non-patency, followed by dyslipidemia. In diabetics, mean
internal radial diameterwas found to be low,whereas hypertension
was not associated signiﬁcantly with the non-patency. Patencywas
higher in taller persons orwith larger BSA, but less in short or in lean
and thin persons, or with smaller BSA. More the wrist diameter or
circumference, greater was the chances of patency. Presence of
pulse does not always indicate the artery is patent, as presence of
good collaterals to maintain circulation may give rise to palpable
pulse. Whereas absence of pulse always indicates that there is
signiﬁcantﬂowreductionornon-patency.There isnegligiblechance
of developing non patent radial artery in cases of repeat procedures
providedcaseselection isdonebymaintaining theabovementioned
exclusion criteria. Re-do procedure does not cause reduction in the
internal diameter of the artery.
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Background: The safety and efﬁcacy of everolimus eluting bioab-
sorbable vascular scaffold (BVS) in themanagement of ‘‘ST’’ eleva-
tion myocardial infarction (STEMI) is yet to be established.
Aims: To evaluate immediate and short-term safety and efﬁcacy of
the everolimus-eluting BVS compared with non BVS drug eluting
stent (DES) in patients with STEMI.
Methods: From January 2013 to December 2014, 220 patients with
STEMI were included in this study. Among them, 35 patients
treated with BVS were compared with a control group composed
of 180 consecutive patients who underwent non BVS DES implan-
tation in the same time period. The incidence of major adverse
cardiac events (MACE: stent thrombosis: death, non-fatal myocar-
dial infarction, or reintervention) before discharge and up to six
months was evaluated.
Results: Single vessel disease was more frequent whereas, double
and triple vessel disease was less frequent in BVS group. Proce-
dural characteristics were also similar between groups, except for
the use of post dilation ( p = 0.04). Procedural success, in-hospital,
and up to six-month MACE rates were similar between both
groups. Deﬁnite or probable in-stent/scaffold thrombosis did not
occurred in BVS patients, though two patients during the index
admission and another two patients in the ﬁrst month after DES
implantation had stent thrombosis.
Conclusion: The use of theAbsorb BVS in this cohort reﬂecting day-
to-day real world clinical practice is feasible and associated with
good procedural safety, and angiographic success rate.
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Background: Although recent studies have demonstrated the
safety and efﬁcacy of everolimus eluting bioabsorbable vascular
scaffold (BVS) in themanagement of stable coronary artery disease
(CAD), but there is lack of data regarding use of BVS for primary
percutaneous coronary intervention (PCI) in management ST seg-
ment elevation myocardial infarction (STEMI).
Aims: To evaluate immediate and short-term safety and efﬁcacy of
the everolimus-eluting BVS in patients with STEMI.
Methods: From January 2013 to December 2014, patients with
STEMI who received BVS implantation during primary PCI were
included in this study.
Results: Among 220 patients of primary PCI, 35 patients received
BVS stent within this study period. Mean age was 59.2  9 years.
Mean duration of follow-up was 11.5  5 months. Eighty percent
patients had single vessel CAD. Femoral access was used in 51%
cases. Mean door-to-balloon time was 93  30 min. Anterior wall
STEMI was more frequent than inferior wall STEMI involving right
coronary artery territory. Mean BVS length and BVS diameter per
patient was 24.6  4.7 mm and 3.2  0.3 mm, respectively. About
66% patients received thrombo aspiration during PCI and throm-
bolysis inmyocardial infarction (TIMI) III ﬂowwas achieved in 94%
patients. Procedural successwas achieved in 94%of the cases. Only
one case had non-cardiac death within one month.
Conclusion: The use of the Absorb BVS in this cohort reﬂecting day-
to-day real world clinical practice is feasible and associated with
good procedural safety and angiographic success rate.
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Case history: A 61-year-old male; Diabetes Mellitus on OHA; K/C/
OMinor CAD (CAG in 2012); Presented with Acute Infero Posterior
wall MI, taken up for Primary Angio Plasty elsewhere, deferred due
to complex anatomy, was thrombolyzed and referred to our hos-
pital for further management.
Techniques/hardware attempted: Guides: JR, AL1, 2; Wires: BMW,
Fielder XT, Grand Slam; Balloon: 1.25, 1.5, 2, 2.5, NC; Stent:
2.75  15, 3  15; Microcatheter: Fine Cross 1.7F; Guideliner: 6F.
Techniques: Double Wire; Conal Artery balloon occlusion; Double
catheter/double wire technique; Double catheter + guideliner
+ grandslam.
Take home message: Tortuosity is always a night mare; Double
GUIDE concept changes device interactions dramatically; Amplatz
Guide + Guideliner + 2 Grandslam provide incremental support;
Even in ACS, hardware choice and Bigger Shelf support matters.
Provisional observation of FFR outcome
proves utility in ambiguous vessel
abnormality
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Introduction: Fractional ﬂow reserve (FFR) is a very handy tool to
determine the precise hemodynamic signiﬁcance of intermediate
epicardial coronary artery stenosis and thus to take appropriate
clinical judgment. Several trails already have identiﬁed its utility
in different clinical set up and parameters but it is still to be
adopted as must have tools in Indian Interventional Niche
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